BRPI0909664A2 - peptídios protetores contra s. pneumoniae e composições, métodos e usos relacionados com os mesmos - Google Patents

peptídios protetores contra s. pneumoniae e composições, métodos e usos relacionados com os mesmos

Info

Publication number
BRPI0909664A2
BRPI0909664A2 BRPI0909664A BRPI0909664A BRPI0909664A2 BR PI0909664 A2 BRPI0909664 A2 BR PI0909664A2 BR PI0909664 A BRPI0909664 A BR PI0909664A BR PI0909664 A BRPI0909664 A BR PI0909664A BR PI0909664 A2 BRPI0909664 A2 BR PI0909664A2
Authority
BR
Brazil
Prior art keywords
pneumoniae
methods
related compositions
peptides against
protective peptides
Prior art date
Application number
BRPI0909664A
Other languages
English (en)
Portuguese (pt)
Inventor
Von Gabain Alexander
Meinke Andreas
Teubenbacher Astrid
Senn Beatrice
Giefing Carmen
Nagy Eszter
Pikalo Jutta
Zerbs Manuel
Hanner Markus
Original Assignee
Intercell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Ag filed Critical Intercell Ag
Publication of BRPI0909664A2 publication Critical patent/BRPI0909664A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G01N2333/3156—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae [Pneumococcus]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
BRPI0909664A 2008-03-17 2009-03-17 peptídios protetores contra s. pneumoniae e composições, métodos e usos relacionados com os mesmos BRPI0909664A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08102655 2008-03-17
PCT/EP2009/053119 WO2009115508A2 (en) 2008-03-17 2009-03-17 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto

Publications (1)

Publication Number Publication Date
BRPI0909664A2 true BRPI0909664A2 (pt) 2019-09-24

Family

ID=40673589

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909664A BRPI0909664A2 (pt) 2008-03-17 2009-03-17 peptídios protetores contra s. pneumoniae e composições, métodos e usos relacionados com os mesmos

Country Status (8)

Country Link
US (3) US8241643B2 (OSRAM)
EP (1) EP2265634A2 (OSRAM)
JP (1) JP2011514167A (OSRAM)
CN (1) CN101977927A (OSRAM)
AU (1) AU2009226949A1 (OSRAM)
BR (1) BRPI0909664A2 (OSRAM)
CA (1) CA2718473A1 (OSRAM)
WO (1) WO2009115508A2 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2718473A1 (en) 2008-03-17 2009-09-24 Intercell Ag Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
JP2016539350A (ja) * 2013-10-09 2016-12-15 ユニバーシティー オブ ロチェスター マルチプレックスな肺炎連鎖球菌血清学のためのチップ、検出システム、及び方法
CN105963691B (zh) * 2016-07-03 2020-05-01 查文娟 一种肺炎链球菌疫苗
WO2023006825A1 (en) * 2021-07-29 2023-02-02 Université de Lausanne Novel pneumococcal polypeptide antigens

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
AU7906691A (en) 1990-05-23 1991-12-10 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Adeno-associated virus (aav)-based eucaryotic vectors
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
DK0772619T4 (da) 1994-07-15 2011-02-21 Univ Iowa Res Found Immunmodulatoriske oligonukleotider
US7081530B1 (en) * 1997-07-02 2006-07-25 sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
EP1144640A3 (en) * 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
DE60130877T2 (de) 2000-04-14 2008-07-17 Intercell Ag Modifizierte peptide enthaltende pharmazeutische präparationen
HU228264B1 (en) 2000-06-08 2013-02-28 Intercell Ag Immunostimulatory oligodeoxynucleotides
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
WO2002013857A2 (en) 2000-08-17 2002-02-21 Intercell Biomedizinische Forschungs- Und Entwicklungs Ag A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
AU2002320762B2 (en) 2001-05-21 2006-09-21 Intercell Ag Immunostimulatory oligodeoxynucleic molecules
EP1450821A1 (en) 2001-12-07 2004-09-01 Intercell AG Immunostimulatory oligodeoxynucleotides
EP1615950A2 (en) * 2003-04-15 2006-01-18 Intercell AG S. pneumoniae antigens
EP1923069A1 (en) 2006-11-20 2008-05-21 Intercell AG Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
CA2718473A1 (en) 2008-03-17 2009-09-24 Intercell Ag Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto

Also Published As

Publication number Publication date
CA2718473A1 (en) 2009-09-24
WO2009115508A3 (en) 2009-11-12
US20110091494A1 (en) 2011-04-21
AU2009226949A1 (en) 2009-09-24
WO2009115508A2 (en) 2009-09-24
CN101977927A (zh) 2011-02-16
US8445001B2 (en) 2013-05-21
US20120294881A1 (en) 2012-11-22
US8241643B2 (en) 2012-08-14
US20130280288A1 (en) 2013-10-24
JP2011514167A (ja) 2011-05-06
EP2265634A2 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
BRPI1008709A2 (pt) composições e usos das mesmas.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0913447A2 (pt) composição de éster, e, composição para cuidado pessoal.
BR112012003792A2 (pt) gel tópico, e, uso do gel tópico.
FR2941231B1 (fr) Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
BRPI1010772A2 (pt) composto,e, composição farmacêutica.
BRPI0915299A2 (pt) poliamida, composição compreendendo tal poliamida e utilização das mesmas
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
HUE056636T2 (hu) Cisz-1,1,1,4,4,4-hexafluor-2-butén azeotróp-jellegû készítményei
BRPI0922043A2 (pt) composições compreendendo um aril pirazol e/ou formamidina, métodos e usos das mesmas
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
BRPI0919412A8 (pt) composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo.
BRPI1014583A2 (pt) sulfonamidas heterocíclicos, composições farmacêuticas e usos do mesmo.
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI0813922A2 (pt) composições de inibição de influenza e métodos.
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BRPI0910378A2 (pt) composições imunogênicas anti-amilóides, métodos e usos
BR112012000379A2 (pt) composições de matriz carreadora, métodos e usos
WO2010046061A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
BRPI0911613A2 (pt) composições de cuidado de cabelo.
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.
BRPI0922081A2 (pt) Combinação de herbicida/agente protetor.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.